American and Chinese researchers have developed synthetic cardiac stem cells that could have the same therapeutic impact as human stem cells, with the added benefit of reducing the risk of graft rejection in cellular therapy. Cellular therapy consists of the injection of stem cells to restore damaged tissue and organs. Scientists today can extract stem cells, clone them in vitro, program their differentiation, limit their potential to cause tumors, and inject them by the million into damaged tissue.
Go here to see the original:
Synthetic stem cells to regenerate heart tissue